| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/2008 | US7402306 Cancer immunotherapy with semi-allogeneic cells |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | CA2384418C Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 07/22/2008 | CA2283420C Lyme disease antigen compositions and uses |
| 07/22/2008 | CA2274474C Synthetic hpv16 virus-like particles |
| 07/22/2008 | CA2271008C Acellular pertussis vaccine with diphtheria- and tetanus-toxoids |
| 07/22/2008 | CA2238661C Killer t cell activator and use thereof |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2220588C Attenuated live neospora vaccine |
| 07/22/2008 | CA2196801C Novel vaccine adjuvant and vaccine |
| 07/22/2008 | CA2173324C Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 07/22/2008 | CA2141427C Expression of recombinant fusion proteins in attenuated bacteria |
| 07/22/2008 | CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto |
| 07/17/2008 | WO2008086395A2 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | WO2008086386A2 Adenoviral vector-based malaria vaccines |
| 07/17/2008 | WO2008086006A2 Sp35 antibodies and uses thereof |
| 07/17/2008 | WO2008085987A2 Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display |
| 07/17/2008 | WO2008085938A2 Antibody inhibiting infection of papillomavirus |
| 07/17/2008 | WO2008085794A2 Methods and compositions related to clot binding compounds |
| 07/17/2008 | WO2008085562A2 Combinatorieal therapy of cancer and infectious diseases with anti-b7-h1 antibodies |
| 07/17/2008 | WO2008085557A2 Alphavirus replicon particles encoding il- 12 as immunological adjuvants |
| 07/17/2008 | WO2008085551A2 Smallpox monoclonal antibody |
| 07/17/2008 | WO2008085486A1 Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 07/17/2008 | WO2008085406A2 Modified live (jmso strain) haemophilus parasuis vaccine |
| 07/17/2008 | WO2008085221A2 Therapeutic use of cd31 expressing cells |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084237A2 Stabilization of aqueous compositions of proteins with displacement buffers |
| 07/17/2008 | WO2008084125A2 Method for the preparation of a scuticociliatosis vaccine for farmed marine fish |
| 07/17/2008 | WO2008084106A1 Anti-kir antibodies, formulations, and uses thereof |
| 07/17/2008 | WO2008084040A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 07/17/2008 | WO2008083949A2 Rna-coded antibody |
| 07/17/2008 | WO2008083432A1 Recombinant antibodies |
| 07/17/2008 | WO2008067283A9 Ovr110 antibody compositions and methods of use |
| 07/17/2008 | WO2008066691A3 Tes7 and antibodies that bind thereto |
| 07/17/2008 | WO2008057696A9 Compositions of pattern recognition receptor-ligand: lipid complexes and methods of use thereof |
| 07/17/2008 | WO2008055916A3 New antigens for paratuberculosis diagnosis and vaccination |
| 07/17/2008 | WO2008052187A3 Antibodies and immunoconjugates and uses therefor |
| 07/17/2008 | WO2008044076A3 Therapy targeting cathepsin s |
| 07/17/2008 | WO2008010101A3 Antagonist antibody against epha2 for the treatment of cancer |
| 07/17/2008 | WO2007145806A3 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 07/17/2008 | WO2007145760A3 Anthrax compositions and methods of use and production |
| 07/17/2008 | WO2007139972A8 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 07/17/2008 | WO2007116409A3 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 07/17/2008 | WO2007097812A3 Therapeutic anti-her2 antibody fusion polypeptides |
| 07/17/2008 | WO2007075879A8 Method for detection of cancer cells using virus |
| 07/17/2008 | WO2007057763A3 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
| 07/17/2008 | US20080172247 Method to Decrease the Risk of a Vaccine-Induced Chronic Immune Mediated Disorder in Humans With a Family History of the Disorder |
| 07/17/2008 | US20080171855 Polyvalent protein complex |
| 07/17/2008 | US20080171714 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171713 Substances for preventing and treating autoimmune diseases |
| 07/17/2008 | US20080171712 At least two oligonucleotides having modified purine bases, such as deazaguanosines or deaza-adenosines, linked by an alkyl or phenolic diol or triol; vaccines, DNA vaccines; anticarcinogenic, antiallergenic, antiinflammatory agents; bronchodilators |
| 07/17/2008 | US20080171703 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171313 Identifying nucleoside resistant hepatitis b virus based on presence of mutation in polymerase gene |
| 07/17/2008 | US20080171079 Administering an immunogenic composition of Varicella-Zoster Virus gE, or immunogenic fragment, and a TH-1 adjuvant |
| 07/17/2008 | US20080171066 Non-pathogenic Bacillus spores comprising a polynucleotide sequence encoding a phagosome membrane-rupturing agent; and a polynucleotide sequence encoding a heterologous polypeptide; immunisation and vaccination |
| 07/17/2008 | US20080171065 Methods of Treating Nerve Entrapment Syndromes |
| 07/17/2008 | US20080171064 Live Attenuated Salmonella For Use as Vaccine |
| 07/17/2008 | US20080171063 Multivalent influenza vaccine in an oil-in-water emulsion of a metabolizable oil (squalene), a sterol and an emulsifier; includes pandemic strains such as H5N1, H9N2, H7N7, H2N2 and H1N1 |
| 07/17/2008 | US20080171062 Hepatitis B surface antigen (HBsAg); contain heterologous polyepitopes fused to the middle (M) envelope protein; useful in immunogenic compositions and as vaccines; expression vector for the production of virus-like particles comprising fusion proteins and S proteins of hepatitis B virus (HBV) |
| 07/17/2008 | US20080171061 Using lentiviral peptide to ellicit CD8+ lymphocyte response to treat and prevent viral infection and viral associated cell proliferative disorders |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171059 Using transgenic cells expressing cancer antigen fusion as inducer of cell-mediated immune response targeting tumor cells; immunotherapy |
| 07/17/2008 | US20080171058 Compositions and Methods For Synergistic Induction of Antitumor Immunity |
| 07/17/2008 | US20080171057 Using proteomic profiles as diagnostic indicators of metabolic disorders; bioinformatics |
| 07/17/2008 | US20080171056 Enhancing therapeutic efficacy of antitumor agents via concurrent expose to receptor specific immunoglobulins; tissue targeted therapy |
| 07/17/2008 | US20080171055 Using blood brain barrier receptor specific immunoglobullin as diagnostic and therapeutic for prevention, detection treatment of brain disorders |
| 07/17/2008 | US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection |
| 07/17/2008 | US20080171053 Polypeptides And Immunogenic Conjugates Capable of Inducing Antibodies Against Pathogens, and Uses Thereof |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171051 Cancer Treatment |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/17/2008 | US20080171048 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/17/2008 | US20080171047 Preventing tissue rejection by administering patient immunoglobulin which reduces integrin alpha E, transforming growth factor and cadherin E expression |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171045 Compositions and Methods for Diagnosing and Treating Cancer |
| 07/17/2008 | US20080171044 Compositions and methods for inhibiting squamous cell carcinoma |
| 07/17/2008 | US20080171043 Cytotoxin conjugated immunoglobulin specific to tripeptide sequence (N'-Trp-Pro-Ile-C') of carcinoembryonic antigen for use in treatment and prevention of cell proliferative disorders |
| 07/17/2008 | US20080171042 Using antisense agents to prevent/reduce cell surface glycoprotein expression and treat cell proliferative disorders of prostate gland |
| 07/17/2008 | US20080171041 Method for treating inflammation |
| 07/17/2008 | US20080171040 Antibody-drug conjugates and methods |
| 07/17/2008 | US20080171039 Zinc transporter protein (LIV-1) specific imunoglobulin for use in prevention and treatment of breast cancer |
| 07/17/2008 | US20080171038 Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| 07/17/2008 | US20080171037 Tumor necrosis factor receptor ligand for use in identifying modulators for prevention and treatment of cell proliferative, nervous system, cardiovascular and autoimmune disorders |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171035 Mammalian cell membrane proteins; related reagents |
| 07/17/2008 | US20080171034 2-Adamantyl-3-hydroxycyclopenta[a]phenanthren-17-yldeneimino-oxy, -amino- and -aminocarbonyl compounds; degenerative diseases including neurodegenerative; ophthalmic; cardiovascular; bone, joint, connective tissue or cartilage; & mitochondrial disorders; transplants; altered activity of excitotoxic path |
| 07/17/2008 | US20080171023 Nutrient broth comprising nervous system tissue is exposed to tumor associated antigen in order to ellicit enhanced CD8+T cell response; administered to cancer patient to treat cell proliferative disorders; immunotherapy |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | US20080171016 Death Domain Containing Receptors |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/17/2008 | US20080171002 Immunostimulants; free of storage protein from nongerminated seeds of Ricinus communis (Castor bean); treating cancer, infections, and pathogenic diseases; AM3 as example; binds to dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) |
| 07/17/2008 | US20080170995 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 07/17/2008 | US20080170994 Diagnosis of brain disorders using antibodies capable of crossing the blood-brain barrier and reacting with the pathological substance; Alzheimer's disease, Parkinson's disease, Huntington's disease, bovine spongiform encephalopathy, West Nile virus encephalitis, brain or spinal cord injury, cancer |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | CA2675291A1 Killer ig-like receptor (kir) antibodies, formulations, and uses thereof |
| 07/17/2008 | CA2675022A1 Adenoviral vector-based malaria vaccines |
| 07/17/2008 | CA2674608A1 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | CA2674603A1 Sp35 antibodies and uses thereof |